Dr Lal Pathlabs Ltd | Industry : (Healthcare) | |
---|---|---|
BSE Code : 539524 |
NSE Symbol : LALPATHLAB |
P/E(TTM) : 66.13 |
ISIN Demat : INE600L01024 |
Div & Yield% : 0.55 |
EPS(TTM) : 49.50 |
Book Value(₹) : 227.31 |
Market Cap(₹Cr) : 27,358.87 |
Face Value(₹) : 10.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 534.50 | 479.00 | 476.00 | 531.70 | 480.10 | 431.00 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 534.50 | 479.00 | 476.00 | 531.70 | 480.10 | 431.00 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 28.80 | 15.90 | 15.10 | 14.10 | 15.00 | 11.60 |
Total Income | 563.30 | 494.90 | 491.10 | 545.80 | 495.10 | 442.60 |
Total Expenditure | 379.00 | 348.70 | 345.90 | 368.70 | 344.30 | 315.30 |
PBIDT | 184.30 | 146.20 | 145.20 | 177.10 | 150.80 | 127.30 |
Interest | 5.50 | 5.90 | 6.50 | 7.10 | 7.30 | 8.40 |
PBDT | 178.80 | 140.30 | 138.70 | 170.00 | 143.50 | 118.90 |
Depreciation | 17.80 | 19.80 | 19.20 | 19.10 | 18.40 | 20.80 |
Tax | 40.50 | 30.00 | 31.90 | 39.80 | 35.90 | 22.10 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -2.40 | 1.00 | -0.70 | -1.90 | -4.40 | 4.60 |
Reported Profit After Tax | 122.90 | 89.50 | 88.30 | 113.00 | 93.60 | 71.40 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 122.90 | 89.50 | 88.30 | 113.00 | 93.60 | 71.40 |
EPS (Unit Curr.) | 14.76 | 10.73 | 10.78 | 13.60 | 11.28 | 8.61 |
EPS (Adj) (Unit Curr.) | 14.76 | 10.73 | 10.78 | 13.60 | 11.28 | 8.61 |
Calculated EPS (Unit Curr.) | 14.72 | 10.72 | 10.57 | 13.53 | 11.22 | 8.56 |
Calculated EPS (Adj) (Unit Curr.) | 14.72 | 10.72 | 10.57 | 13.53 | 11.22 | 8.56 |
Calculated EPS (Ann.) (Unit Curr.) | 58.87 | 42.87 | 42.30 | 54.13 | 44.89 | 34.24 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 58.87 | 42.87 | 42.30 | 54.13 | 44.89 | 34.24 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 60.00 | 0.00 |
Equity | 83.50 | 83.50 | 83.50 | 83.50 | 83.40 | 83.40 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 34.48 | 30.52 | 30.50 | 33.31 | 31.41 | 29.54 |
PBDTM(%) | 33.45 | 29.29 | 29.14 | 31.97 | 29.89 | 27.59 |
PATM(%) | 22.99 | 18.68 | 18.55 | 21.25 | 19.50 | 16.57 |